4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0000950170-24-030309
President and CEO sold 183,238 shares at an average $3.17 ($580,760)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Brady Todd C President and CEO | 2024-03-11 | Sale | −97,914 | $3.27 | $320,521 | 1,556,622 | D |
| Brady Todd C President and CEO | 2024-03-12 | Sale | −85,324 | $3.05 | $260,238 | 1,471,298 | D |
| Derivatives | |||||||
| Brady Todd C President and CEO | 2024-03-09 | Grant or award · Stock Option (right to buy) | +1,081,201 | 1,081,201 | D | ||
| Open-market sales · 183,238 sh · avg $3.17 · $580,760 | |||||||
Loading xslF345X05/ownership.xml…